CVB Financial Corp. (CVBF)

CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	738.64	204.7	281.29	203.46	1,733	1,958
Investment Securities	11	1,151	1,136	1,122	909.22	420.31
Trading Asset Securities	-	8.09	1.24	0.08	14.16	30.18
Mortgage-Backed Securities	4,814	3,884	4,363	4,763	4,291	2,659
Total Investments	4,825	5,044	5,500	5,885	5,215	3,110
Gross Loans	8,359	8,536	8,905	9,079	7,888	8,349
Allowance for Loan Losses	-78	-80.12	-86.84	-85.12	-65.02	-93.69
Net Loans	8,280	8,456	8,818	8,994	7,823	8,255
Property, Plant & Equipment	26.61	74.66	66.36	69.39	68.37	70.26
Goodwill	765.82	765.82	765.82	765.82	663.71	663.71
Other Intangible Assets	7.66	9.97	15.29	21.74	25.39	33.63
Accrued Interest Receivable	-	45.72	48.99	46.69	34.2	31.31
Other Receivables	-	4.17	3.18	2.4	7.6	8.02
Other Current Assets	-	13.07	9.48	8.71	7.96	6.93
Long-Term Deferred Tax Assets	-	167.01	175.78	184.29	25	21.52
Other Real Estate Owned & Foreclosed	0.66	19.3	-	-	-	3.39
Other Long-Term Assets	751.7	331.29	318.58	267.16	263.72	239.66
Total Assets	15,414	15,154	16,021	16,477	15,884	14,419
Accounts Payable	-	-	-	-	50.34	60.11
Interest Bearing Deposits	4,738	4,810	4,021	4,595	4,792	4,181
Institutional Deposits	-	101.5	206.4	77.2	79.9	100.3
Non-Interest Bearing Deposits	7,247	7,037	7,206	8,164	8,104	7,455
Total Deposits	11,985	11,948	11,434	12,836	12,976	11,737
Short-Term Borrowings	404.15	262.43	2,349	1,561	658.83	474.59
Current Portion of Leases	-	10.11	-	-	-	-
Accrued Interest Payable	-	5.05	23.27	0.43	-	-
Federal Home Loan Bank Debt, Long-Term	200	500	-	-	-	-
Long-Term Leases	-	39.5	24.06	24.46	20.86	21.16
Trust Preferred Securities	-	-	-	-	-	25.77
Other Long-Term Liabilities	284.83	201.86	113.36	106.37	95.72	93.19
Total Liabilities	13,174	12,967	13,943	14,528	13,802	12,411
Common Stock	2,508	1,297	1,289	1,300	1,210	1,212
Retained Earnings	-	1,201	1,113	1,003	875.57	760.86
Comprehensive Income & Other	-268.13	-312.06	-323.57	-354.8	-3.97	35.35
Shareholders' Equity	2,240	2,186	2,078	1,949	2,082	2,008
Total Liabilities & Equity	15,414	15,154	16,021	16,477	15,884	14,419
Total Debt	904.15	812.05	2,373	1,585	679.7	521.53
Net Cash (Debt)	-154.51	-598.79	-2,082	-1,372	1,093	1,510
Net Cash Growth	-	-	-	-	-27.63%	-
Net Cash Per Share	-1.11	-4.32	-15.04	-9.80	8.07	11.09
Filing Date Shares Outstanding	137.83	139.62	139.37	139.51	141.92	135.87
Total Common Shares Outstanding	137.83	139.69	139.34	139.82	135.53	135.6
Book Value Per Share	16.25	15.65	14.91	13.94	15.36	14.81
Tangible Book Value	1,467	1,411	1,297	1,161	1,392	1,311
Tangible Book Value Per Share	10.64	10.10	9.31	8.30	10.27	9.67

Updated May 9, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q